Last $118.32 USD
Change Today -0.63 / -0.53%
Volume 14.0K
WAT On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 9:41 AM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

waters corp (WAT) Snapshot

Open
$118.80
Previous Close
$118.95
Day High
$119.03
Day Low
$118.05
52 Week High
01/27/15 - $122.80
52 Week Low
10/15/14 - $93.56
Market Cap
9.9B
Average Volume 10 Days
527.4K
EPS TTM
$5.42
Shares Outstanding
83.3M
EX-Date
--
P/E TM
21.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for WATERS CORP (WAT)

waters corp (WAT) Related Businessweek News

View More BusinessWeek News

waters corp (WAT) Details

Waters Corporation operates as an analytical instrument manufacturer in the United States and internationally. The company's Waters division designs, manufactures, sells, and services high performance liquid chromatography, ultra performance liquid chromatography, and mass spectrometry technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. This segment’s products are used to detect, identify, monitor, and measure the chemical, physical, and biological composition of materials, as well as to purify a range of compounds. Its products are also used in drug discovery and development, including clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its TA division offers thermal analysis, rheometry, and calorimetry instruments, which are used in predicting the suitability of fine chemicals, pharmaceuticals, water, polymers, and viscous liquids for uses in various industrial, consumer goods, and healthcare products, as well as for life science research. The company also develops and supplies software-based products that interface with its instruments. Its products are used by pharmaceutical, life science, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is based in Milford, Massachusetts.

waters corp (WAT) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $774.0K
Executive Vice President and President of the...
Total Annual Compensation: $493.3K
Vice President, General Counsel and Secretary
Total Annual Compensation: $389.0K
Vice President of Human Resources
Total Annual Compensation: $238.0K
Advisor
Total Annual Compensation: $402.3K
Compensation as of Fiscal Year 2013.

waters corp (WAT) Key Developments

Waters Corporation Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Earnings Guidance for the First Quarter and Year 2015

Waters Corporation announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. The company reported fourth quarter 2014 sales of $584 million, an increase of 3% in comparison to sales of $565 million in the fourth quarter of 2013. In the quarter, the effect of foreign currency translation reduced sales by 5%. Operating income was $172.039 million against $176.177 million a year ago. Income from operations before income taxes was $164.473 million against $169.325 million a year ago. Net income was $151.292 million against $141.582 million a year ago. On a GAAP basis, earnings per diluted share (EPS) for the fourth quarter were $1.80 compared to $1.65 for the fourth quarter of 2013. On a non-GAAP basis EPS grew 17% to $1.99 from $1.70 in the fourth quarter of 2013. Adjusted non-GAAP operating income was $193.251 million against $181.515 million a year ago. Adjusted non-GAAP net income was $167.181 million against $146.204 million a year ago. The company generated healthy free cash flow at about $150 million after funding $21 million for capital expenditures, a level which does not include $2 million of spending associated with major facility construction. For the full year, sales for the Company were $1.99 billion, an increase of 4% in comparison to sales of $1.90 billion in 2013, with foreign currency translation reducing sales growth by about 2%. Operating income was $517.908 million against $517.343 million a year ago. Income from operations before income taxes was $490.740 million against $490.105 million a year ago. Net income was $431.620 million against $450.003 million a year ago. On a GAAP basis, EPS for 2014 were $5.07 compared to $5.20 in 2013. On a non-GAAP basis EPS grew 9% to $5.48 from $5.04 in 2013. Adjusted non-GAAP operating income was $561.695 million against $536.806 million a year ago. Adjusted non-GAAP net income was $466.464 million against $435.964 million a year ago. Non-GAAP earnings per fully diluted shares were up around 9% to $5.47 per share versus $5.04 last year. The company also provided earnings guidance for the first quarter and year 2015. The company reported that, looking ahead to 2015, it assumes a continuation of the market conditions that it saw in 2014. Specifically, it is envisioning stable increases in recurring revenue sales in combination with continued growth in sales to broadly defined pharmaceutical sector. TA Instruments division will combine to help support a mid-single-digit organic sales increase in 2015. Full year 2015 earnings per fully diluted share are projected to be within a range of $5.55 to $5.80. Looking at the first quarter of 2015, it is estimating that sales will grow at a high single-digit rate due to a relatively favorable base of comparison and 4 additional business days in the quarter. Currency translation at present rates is expected to reduce first quarter sales growth by about 5%. First quarter earnings per diluted share expected to be in the range of between $0.95 and $1.05.

Waters Corp Mulls Acquisitions

Waters Corporation (NYSE:WAT) is looking for acquisitions. Douglas Berthiaume, Chairman, President and Chief Executive Officer of Waters Corporation said, "On the M&A front, it is highly unlikely that you'll see us in pursuit of a major acquisition and more likely that we'll continue to target smaller, bolt-on businesses and technical acquisitions."

Waters Corporation Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015 03:30 PM

Waters Corporation Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015 03:30 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Douglas A. Berthiaume, Chairman, Chief Executive Officer and President.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WAT:US $118.32 USD -0.63

WAT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cintas Corp $78.23 USD -0.115
Hospira Inc $63.89 USD -0.76
Mettler-Toledo International Inc $300.08 USD +0.31
PerkinElmer Inc $44.03 USD -0.46
WR Grace & Co $86.81 USD +0.27
View Industry Companies
 

Industry Analysis

WAT

Industry Average

Valuation WAT Industry Range
Price/Earnings 23.5x
Price/Sales 5.0x
Price/Book 5.2x
Price/Cash Flow 22.4x
TEV/Sales 3.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WATERS CORP, please visit www.waters.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.